Home > Products > CD45 & Myosin
> Recombinant Anti-CD45 x Anti-Myosin Bispecific Antibody (scIgG)
Recombinant Anti-CD45 x Anti-Myosin Bispecific Antibody (scIgG) (CAT#: SCIGG-122)
Recombinant Anti-CD45 x Anti-Myosin Bispecific Antibody (scIgG) is designed to be expressed as two chains, each chain has the same units with their parental IgG antibodies, anti-CD45 and anti-Myosin IgGs. The two chains form heterodimer via Fc KIH technology. This BsAb can recruit stem cells to infarcted myocardium. It is designed for the research of Myocardial infarction therapy.
There are currently no customer reviews or questions for Recombinant Anti-CD45 x Anti-Myosin Bispecific Antibody (scIgG) (SCIGG-122). Click the button below to contact us or submit your feedback about this product.